Education, Science, Technology, Innovation and Life
Open Access
Sign In

Progress in Traditional Chinese and Western Medicine in Mycoplasma Pneumonia in Children

Download as PDF

DOI: 10.23977/medsc.2022.030101 | Downloads: 5 | Views: 644

Author(s)

Yarong Hao 1, Shijie Luo 2, Lin Wang 3, Yu Zhong 1

Affiliation(s)

1 Shaanxi University of Traditional Chinese Medicine; Middle Section of Century Avenue, Xianyang City, Shaanxi Province, 712000, China
2 The Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi Province, 712000, China
3 Shangluo University; No.10 North New Street, Shangluo City, Shaanxi Province, 726000, China

Corresponding Author

Yarong Hao

ABSTRACT

Mycoplasma pneumonia in children is a common and frequently occurring disease in pediatrics. In addition to the respiratory symptoms, clinical manifestations often involve digestive, blood and cardiovascular systems, which have a serious impact on the health and life of children. At present, the treatment is mainly on macrolide antibiotics, immunotherapy, and integrated traditional Chinese and western medicine. Because the pathogenesis of mycoplasma pneumonia is not very clear, and the clinical manifestations are lack of specificity, and the macrolide antibiotic resistance rate is gradually increased, which poses new challenges to the diagnosis and treatment program of mycoplasma pneumonia. According to the incidence characteristics of mycoplasma pneumonia in children, this paper reviews the relevant literature in recent years, and reviews the progress of the diagnosis and treatment of mycoplasma pneumonia in children.

KEYWORDS

Children, mycoplasma pneumonia, review

CITE THIS PAPER

Yarong Hao, Shijie Luo, Lin Wang, Yu Zhong, Progress in Traditional Chinese and Western Medicine in Mycoplasma Pneumonia in Children. MEDS Clinical Medicine (2022) Vol. 3: 1-6. DOI: http://dx.doi.org/10.23977/medsc.2022.030101.

REFERENCES

[1] GAOLW, YINJ, HUYH, etal. The epidemiology of paediatric mycoplasma pneumoniae pneumonia in North China: 2006 to 2016 [J]. Epidemiol Infect, 2019, 147: e192.
[2] Liang Shijia, Li Jiujun.Progress in the diagnosis and treatment of refractory mycoplasma pneumonia in children [J]. Journal of Community Medicine, 2020, 18 (04): 304-308.
[3] Da Xiaohu, Li Yunsheng. Progress of Mycoplasma pneumoniae [J]. Clinical Medical Research and Practice, 2016, 1 (17): 197-198.
[4] Editorial Committee of the Chinese Clinical Journal of Practical Pediatrics, Respiratory Group, Branch of Pediatrics, Chinese Medical Association. Expert Consensus on the diagnosis and Treatment of Mycoplasma pneumonia in children (2015 edition) [J]. Chinese Journal of Practical Pediatric Clinical Medicine 2015, 30(17): 1304-1308. DOI: 10.3760/ cma.j.issn.2095-428X.2015.17.006.
[5] Chinese Medicine Association.Expert consensus on the diagnosis and treatment of integrated Chinese and Western medicine in Mycoplasma pneumonia (formulated in 2017) [J]. Chinese Journal of Practical Pediatrics, 2017, 32 (12): 881-885.
[6] Huang Jianzhen.Progress in pediatric mycoplasma pneumonia treatment [J].Health of Urban and Rural Enterprises in China, 2021, 36(12):26-28.DOI:10.16286/j.1003-5052.2021.12.009.
[7] Li Wen.How does Mycoplasma pneumoniae pneumonia is diagnosed in children [J].Diet Health Care, 2020, 5 (07): 139-140.
[8] Li Xinxin. Application value of mycoplasma pneumonia antibody immunoglobulin G, immunoglobulin M, and deoxyribonucleic acid detection in the diagnosis of respiratory infections in children [J]. Heilongjiang Medicine, 2021, 45 (23): 2552-2553 + 2556.
[9] Chen D, Zhang Y, Xu Y, etal. Comparison of chemiluminescence immunoassay, enzyme-linked immunosorbent assay and passive agglutination for diagnosis of infection [J]. Ther Clin RiskManag, 2018, 14: 1091-1097.
[10] Zhao Moral Education, Deng Huan.Significance and progress of the laboratory diagnosis of Mycoplasma pneumoniae pneumonia [J].The Chinese Clinical Journal of Practical Pediatrics, 2021, 36 (16): 1205-1209.
[11] Sun Juanzi, Sun Sujuan, Bai Jiaolong, Li Yuanyuan.Comparison of the diagnosis of enzyme-linked immunosorbent and agglutination assay in early mycoplasma pneumoniae infection [J]. China Medical Engineering, 2021, 29(06): 15-17.
[12] Sun Weicai, Tian Tian.The diagnostic value of rapid serology and microbiological culture testing for pediatric Mycoplasma pneumoniae infection [J]. Journal of Practical Medical Technology, 2021, 28 (12): 1460-1462.
[13] Xie Hongbo, Wang Chunfeng, Chen Hydrologic, Wang Shijun, Liu Junyi.Study of nucleic acid detection of Mycoplasma pneumoniae in sputum [J]. Chinese Medical Sciences, 2019, 9 (19): 142-145.
[14] Xie Weibo, Xie Junbo, Yin Xiaofeng, Xu Jin.Analysis of pediatric community acquired Mycoplasma pneumoniae pneumonia [J]. Modern Medicine and Health Care, 2021, 37 (01): 26-29.
[15] Zhao Chengwei. Characteristics of chest CT imaging and clinical diagnosis of children with Mycoplasma pneumoniae pneumonia [J]. Medical Device Information in China, 2021, 27 (06): 157-159.
[16] Wang Huiguang.Comparison of computed X-ray tomography and X-ray chest ray in diagnosis of children with Mycoplasma pneumoniae pneumonia [J]. Inner Mongolia Medical Journal, 2021, 53 (12): 1470-1472.
[17] Zhang Ning, Wang Tao, Tan Qingti.Imaging characteristics of chest CT and its differential diagnosis in pediatric mycoplasma pneumonia [J]. Chinese CT and MRI Magazine, 2021, 19 (12): 36-38.
[18] Wang Qian, Wang Yi, Du Jieying, Xie Guangcheng, and Liu Jianying.Analysis of the clinical data and imaging characteristics of children with severe Mycoplasma pneumoniae pneumonia [J]. Medical Theory and Practice, 2019, 32 (06): 894-896.
[19] Zhao Orchid, Yang Shuhui, Ma Lin.Comparison of pulmonary characteristics and diagnostic value of HRCT in the acute phase of Mycoplasma pneumoniae pneumonia [J]. Image Science and Photochemistry, 2021, 39 (04): 584-588.
[20] Wu Xiaolei.Effect analysis of azithromycin sequential therapy on pediatric treatment of mycoplasma pneumoniae pneumonia and effect analysis on pediatric respiratory system [J]. Journal of Mathematical Medicine, 2020, 33 (11): 1676-1678.
[21] Zhang Zhixin.Efficacy and safety of azithromycin as an adjuvant treatment for mycoplasma pneumonia in children [J]. The Journal of Clinical Rational Drug Use, 2021, 14(25): 151-153.DOI:10.15887/j.cnki.13-1389/r.2021.25.060.
[22] Liu Xiaomeng, Zhang Yanni North, Yu Haiming, Zhang He, Sun Yuanyuan.Effect of sodium methylprednisolone succinate on severe mycoplasma pneumonia and its effect on inflammatory factors in children [J]. China Pharmaceutical Guide, 2021, 18 (29): 98-101.
[23] Zhao Jing, Xu Darong.Analysis of the efficacy of methylprednisolone combined with inhaled corticosteroids on refractory Mycoplasma pneumoniae pneumonia in children [J]. Chinese Community Physician, 2021, 37 (28): 78-79.
[24] Zhao Chunyang, Cai Jiayi, Jiang Mingyan.Systematic evaluation analysis of the role of glucocorticoids in the treatment of mycoplasma pneumonia in children [J]. Journal of Clinical Drug Therapy, 2016, 14 (01): 28-34.
[25] Zuo Zhiyan.Effect of budesonide atomization inhalation on pediatricmycoplasma pneumonia and its effect on pulmonary function [J]. Journal of Clinical Rational Drug Use, 2020, 13 (32): 93-94.
[26] Gong Wenhao, Lan Tianying, Mo Qinglian, Yang Yan, Dai Qigang, Chen Sasha, Tang Zixi, Liu Yujiang, Ai Jun. Characteristics of 493 children with Mycoplasma pneumoniae [J]. Chinese Journal of Traditional Chinese Medicine, 2021, 36 (10): 6097-6100.
[27] Wang Nan, Qi Zhaodong, Hou Hongbin, Wu Zhenfeng.From the theory of "pulmonary bi" about refractory mycoplasma pneumonia [J]. Journal of Changchun University of Traditional Chinese Medicine, 2021, 37(03): 489-492 .DOI: 10.13463/j.cnki.cczyy.2021.03.005.
[28] Li Na, Zhang Baoqing, Lao Huimin.Analysis of the medication rules of mycoplasma pneumonia in children based on the TCM inheritance auxiliary platform [J]. Traditional Chinese medicine Guide, 2019, 25 (7): 12-15.
[29] Yao Bo.Clinical study of mycoplasma pneumoniae (sputum heat and closed lung certificate) [D]. Changchun University of Traditional Chinese Medicine, 2021.DOI:10.26980/d.cnki.gcczc.2021.000258.
[30] Deng Kun, Lai Haiyan, Long Juan, Ren Mengyao, Yi Wei.Research overview of TCM treatment pediatric Mycoplasma pneumoniae pneumonia [J]. Journal of Guangxi University of Traditional Chinese Medicine, 2021,24 (02): 90-93.
[31] Yang Jie, Zhang Jingjie, Xiao Hui, Li Jing.Effect and safety of traditional Chinese medicine acupoint application combined with azithromycin in treating mycoplasma pneumonia in children [J]. Clinical Medical Research andPractice, 2021, 6(25): 141-143. DOI: 10.19347/j.cnki.2096-1413.202125044.
[32] Yu Chunyan, Xu Weimin, Jin Song, Yang Xiang.Clinical observation of lung chemistry and phlegm soup combined with western medicine in the treatment of pediatric mycoplasma pneumonia [J]. China Traditional Chinese Medicine Technology, 2020, 27 (06): 936-937.
[33] Lv Weigang, Zhang Yan, Song Guihua, Guan Zhiwei, Yu Suping, Guo Yanrong, Chen Xiaosong, Zhang Guichun, Yang Xiaoqing, Sun Mengmeng, Zhang Frozen, Han Yuxia.A randomized control study of mycoplasma pneumoniae pneumonia with phlegm heat pulmonary obstruction and blood stasis [J]. Chinese Journal of Integrated Traditional Chinese and Western Medicine, 2021, 41 (10): 1192-1196.
[34] Qian Fuhong.Clinical observation of 40 cases of children with integrated traditional Chinese and Western medicine [J]. Journal of TCM Pediatrics, 2018, 14 (06): 35-38.

Downloads: 3870
Visits: 167021

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.